Retatrutide Dosage Based on Clinical Studies: The Scientific Foundation Dosing guidelines for retatrutide are based on the Phase 2 data published by Jastreboff and colleagues in NEJM (2023) and, as of 2026, on the first Phase 3 data from TRIUMPH-4
Following these guidelines and keeping up with medical guidance ensures patients can safely and effectively use Vitamin B12 injection therapy
The group's website states that it is an educational academy, not a licensing or accrediting body. After the meeting, the FDA will review the votes, discussion and public comments before making a decision on whether to ease access to the peptides
For example, if they experience dizziness, they should avoid driving
Understanding how long semaglutide treatment typically lasts provides context for this long-term planning
Neelakantan H, Wang HY, Vance V, et al